Investors Research Corp’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24 | Hold |
100
| – | – | ﹤0.01% | 921 |
|
|
2025
Q1 | $20 | Hold |
100
| – | – | ﹤0.01% | 958 |
|
|
2024
Q4 | $54 | Hold |
100
| – | – | ﹤0.01% | 932 |
|
|
2024
Q3 | $95 | Hold |
100
| – | – | ﹤0.01% | 959 |
|
|
2024
Q2 | $97 | Hold |
100
| – | – | ﹤0.01% | 1038 |
|
|
2024
Q1 | $158 | Hold |
100
| – | – | ﹤0.01% | 1004 |
|
|
2023
Q4 | $79 | Hold |
100
| – | – | ﹤0.01% | 1046 |
|
|
2023
Q3 | $78 | Sell |
100
-100
| -50% | -$78 | ﹤0.01% | 1056 |
|
|
2023
Q2 | $185 | Buy |
+200
| New | +$185 | ﹤0.01% | 1054 |
|